Berberine + Chromium
by Metabolic Maintenance
Berberine plus chromium for practitioner-guided glucose and lipid metabolism support.
Supports
- Metabolic / Blood Sugar
- Heart & Cardiovascular
Overview
Each capsule combines 500 mg of berberine HCl with 200 mcg of chromium as chromium picolinate. Berberine has been studied in adults with metabolic disorders for effects on glucose, insulin-resistance, and lipid biomarkers. Chromium is an essential trace mineral involved in normal macronutrient metabolism, although clinical supplementation results are variable.
Evidence Note
Randomized-trial meta-analyses show favorable effects of berberine supplementation on fasting glucose, HbA1c, insulin-resistance measures, LDL cholesterol, triglycerides, and related metabolic biomarkers. This formula pairs 500 mg of berberine HCl with chromium, an essential trace mineral involved in normal macronutrient metabolism.
Key Benefits
- Supports normal glucose metabolism.
- May support healthy insulin-response and lipid biomarkers.
- Provides chromium for normal macronutrient metabolism.
What's Inside — Per Capsule
- Berberine HCl (from Berberis aristata) — 500 mg
- Chromium (as chromium picolinate) — 200 mcg
Suggested Use
Take 1 capsule 1–2 times daily with meals, or as directed by your healthcare practitioner.
Important Safety Considerations
- Do not use during pregnancy or breastfeeding unless specifically directed by the clinician managing your care.
- Berberine can interact with medications and may affect glucose control. Review use with your healthcare professional if you take prescription medication, especially glucose-lowering drugs or drugs with narrow therapeutic ranges.
- Gastrointestinal effects such as constipation or diarrhea can occur.
Research & References
- Berberine and Glycemic / Insulin-Related Traits — Systematic Review and Meta-analysis of Randomized Trials
- Berberine for Dyslipidemia — Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
- Berberine, Glycemic Control, and Inflammatory Biomarkers — Umbrella Meta-analysis
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
